foxo4-dri p53 The disordered transactivation domain is the target of FOXO4 and the senolytic compound Development of a novel senolytic
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Analysis of the 2 predicted binding pockets of FOXO4 DRI. (A) Surface Download Scientific Diagram Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 an overview ScienceDirect Topics
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



